Abstract
Hemodynamic benefits of milrinone administration are accompanied by adverse effects on arterial oxygenation in mechanically ventilated patients with end-stage heart failure. Particular attention should be focused on pulmonary gas exchange variables after initiation of milrinone treatment in the critically ill patient.
MeSH terms
-
Aged
-
Cardiotonic Agents / pharmacology*
-
Cardiotonic Agents / therapeutic use
-
Catecholamines / therapeutic use
-
Female
-
Heart Failure / drug therapy
-
Heart Failure / physiopathology*
-
Heart Failure / therapy
-
Humans
-
Male
-
Middle Aged
-
Milrinone / pharmacology*
-
Milrinone / therapeutic use
-
Pulmonary Gas Exchange / drug effects*
-
Respiration, Artificial
Substances
-
Cardiotonic Agents
-
Catecholamines
-
Milrinone